Form 4: Clover Health VP Sells Shares for Tax Withholding

Clover Health Investments Corp. VP of Finance and Controller, Joseph Frank Oldakowski, sold 12,102 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health Investments, Corp., sold 12,102 shares of Class A Common Stock on June 16, 2026.
• The sale was executed at a price of $4.86 per share.
• These shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units (RSUs).
• This transaction was mandated by the company's policy to satisfy tax withholding through a 'sell to cover' mechanism.
• The sale does not represent a discretionary trading decision by the reporting person.
• Following the transaction, Oldakowski beneficially owns 299,067 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, mandated transaction for tax purposes and does not indicate a change in the executive's confidence in the company.

Positives

• The transaction is a standard procedure for covering tax liabilities associated with equity awards, indicating normal operational processes.
• The company has a clear policy for managing tax withholding obligations related to RSUs, ensuring compliance.
• The reporting person continues to hold a significant number of shares (299,067) after the transaction.

Negatives

• A portion of the reporting person's equity award was sold, which could be perceived negatively by some investors, although it's for tax purposes.
• The sale occurred at a price of $4.86 per share, which may be below the purchase price of the RSUs or the current market price at the time of vesting.

Risks

• The filing does not explicitly mention any new or emerging risks.
• The primary risk is the potential for negative market perception of insider selling, even if for tax reasons.

Future Outlook

The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person. Future sales may occur to cover tax obligations upon subsequent vesting events.

Management Comments

• The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25% of restricted stock units ('RSUs') originally granted to the Reporting Person on June 16, 2025.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions for tax withholding are a common and expected practice for executives receiving equity awards across the tech and healthcare industries. This filing reflects standard compensation and tax management rather than a strategic shift or negative view on the company's prospects by management.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related transaction and is not expected to have a significant impact on the share price. It does not reflect a change in management's conviction about the company's future.
• Employees: This filing pertains to an executive's compensation and tax management, with no direct impact on other employees.
• Management: The transaction is a standard part of the executive compensation plan, ensuring compliance with tax laws.

Next Steps

• Continued vesting of remaining RSUs quarterly until June 16, 2029.
• Potential future 'sell to cover' transactions to satisfy tax withholding obligations upon subsequent vesting events.

Key Dates

Keywords

Form 4, Insider Trading, Stock Sale, Tax Withholding, RSU Vesting, Clover Health, CLOV, Joseph Frank Oldakowski, Beneficial Ownership, Securities Exchange Act